You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced triple-negative breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Triple Negative Breast Cancer Trial in Shantou (SZ011 CAR-NK)

Not yet recruiting
  • Advanced Triple Negative Breast Cancer
  • SZ011 CAR-NK
  • Shantou, China
    Shantou
Jan 9, 2023

Breast Cancer, Chemo Effect Trial in Beijing (Chidamide)

Recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 17, 2023

Triple Negative Breast Cancer Trial (Ociperlimab, Tislelizumab, Paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Mar 30, 2023

Triple Negative Breast Cancer Metastatic Trial in Milano, Padova (Ceralasertib, Durvalumab, Nab-paclitaxel)

Recruiting
  • Triple Negative Breast Cancer Metastatic
  • Milano, Italy
  • +1 more
Jan 16, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast Cancer Trial in Changsha, Xiangyang (AK117,

Recruiting
  • Metastatic Triple-negative Breast Cancer
  • Locally Advanced Triple-negative Breast Cancer
  • Changsha, China
  • +1 more
Sep 8, 2022

Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Active, not recruiting
  • Advanced Breast Cancer
  • +2 more
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 16, 2022

Breast Tumor Female Trial (AK105, Anlotinib HCl, Albumin Paclitaxel)

Not yet recruiting
  • Breast Neoplasm Female
  • (no location specified)
Jul 11, 2022

Advanced Triple Negative Breast Cancer Trial in Newport Beach (N-803, PD-L1 t-haNK, Sacituzumab Govitecan-Hziy)

Active, not recruiting
  • Advanced Triple Negative Breast Cancer
  • N-803
  • +3 more
  • Newport Beach, California
    Hoag Memorial Hospital
Mar 29, 2022

TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 5, 2023

Breast Cancer Trial in Shanghai (ABX, cisplatin, Gemcitabine, Cisplatin)

Completed
  • Breast Cancer
  • ABX, cisplatin
  • Gemcitabine, Cisplatin
  • Shanghai, China
    Fudan University Cancer Hospital
Apr 20, 2022

EGFR/ B7H3-positive Advanced Lung Cancer, EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer Trial in Guangzhou

Recruiting
  • EGFR/ B7H3-positive Advanced Lung Cancer
  • EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
  • EGFR/B7H3 CAR-T
  • Guangzhou, Guangdong, China
    Second Affiliated Hospital of Guangzhou Medical University
Apr 18, 2022

Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

Not yet recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
Aug 31, 2023

Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Trastuzumab Deruxtecan
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jul 12, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Triple-Negative Breast Cancer Trial in Shanghai (VEGFR, nab-paclitaxel, Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin)

Recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Mar 28, 2023

Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 2, 2023

Triple-negative Breast Cancer Trial in China (Chiauranib, capecitabine)

Recruiting
  • Triple-negative Breast Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Apr 14, 2022

Advanced Triple Negative Breast Cancer Trial in Fuzhou (Apatinib Mesylate, Albumin-Bound Paclitaxel)

Not yet recruiting
  • Advanced Triple Negative Breast Cancer
  • Apatinib Mesylate
  • Albumin-Bound Paclitaxel
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Aug 18, 2021

Triple-Negative Breast Cancer Trial in Shanghai (Famitinib, Camrelizumab, nab-Palitaxel/Capecitabine/Eribulin

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Feb 27, 2023

Metastatic Triple-Negative Breast Cancer Trial in Beijing (Anlotinib, Capecitabine)

Recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Beijing, Beijing, China
  • +1 more
Dec 18, 2021

Triple Negative Breast Cancer Trial in Shanghai (Camrelizumab Plus Chemotherapy, +chemo)

Recruiting
  • Triple Negative Breast Cancer
  • Camrelizumab Plus Chemotherapy
  • placebo+chemotherapy
  • Shanghai, China
    Fudan University Cancer Hospital
Feb 9, 2022

Triple Negative Breast Cancer (TNBC) Trial in China (B013+Nab-Paclitaxel)

Recruiting
  • Triple Negative Breast Cancer (TNBC)
  • Guangzhou, Guangdong, China
  • +6 more
Jan 29, 2023

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial in United States (Paclitaxel, CB-839)

Completed
Has Results
  • Triple Negative Breast Cancer
  • TNBC - Triple-Negative Breast Cancer
  • Birmingham, Alabama
  • +24 more
Sep 19, 2022

Breast Cancer, Inflammatory Breast Cancer Stage IV, Inflammatory Breast Tumors Trial in Knoxville (Self-Administered Hypnosis,

Recruiting
  • Breast Cancer
  • +4 more
  • Self-Administered Hypnosis
  • Self-Administered White Noise Hypnosis
  • Knoxville, Tennessee
    University of Tennessee Knoxville
Sep 26, 2023